Wealthcare Advisory Partners LLC Buys 1,056 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Wealthcare Advisory Partners LLC raised its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 26.4% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 5,060 shares of the medical equipment provider's stock after purchasing an additional 1,056 shares during the quarter. Wealthcare Advisory Partners LLC's holdings in Intuitive Surgical were worth $2,506,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. Norges Bank bought a new stake in Intuitive Surgical in the fourth quarter worth $2,401,493,000. GAMMA Investing LLC increased its holdings in shares of Intuitive Surgical by 54,010.7% during the 1st quarter. GAMMA Investing LLC now owns 3,028,576 shares of the medical equipment provider's stock valued at $14,999,630,000 after acquiring an additional 3,022,979 shares during the last quarter. Proficio Capital Partners LLC increased its holdings in shares of Intuitive Surgical by 89,098.8% during the 4th quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider's stock valued at $495,845,000 after acquiring an additional 948,902 shares during the last quarter. Capital Research Global Investors raised its stake in shares of Intuitive Surgical by 25.5% in the 4th quarter. Capital Research Global Investors now owns 3,381,302 shares of the medical equipment provider's stock valued at $1,764,904,000 after acquiring an additional 687,906 shares in the last quarter. Finally, Raymond James Financial Inc. acquired a new stake in Intuitive Surgical in the 4th quarter worth approximately $313,769,000. Hedge funds and other institutional investors own 83.64% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on ISRG shares. BTIG Research set a $560.00 target price on shares of Intuitive Surgical and gave the company a "buy" rating in a research note on Monday, April 14th. Deutsche Bank Aktiengesellschaft cut shares of Intuitive Surgical from a "hold" rating to a "sell" rating and decreased their price target for the company from $515.00 to $440.00 in a report on Monday. Truist Financial dropped their price objective on Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating on the stock in a research note on Wednesday, April 23rd. Citigroup restated a "buy" rating and set a $650.00 target price (up previously from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. Finally, Royal Bank of Canada dropped their price target on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 23rd. One research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $588.95.

Insider Buying and Selling

In related news, Director Jami K. Nachtsheim sold 2,400 shares of the company's stock in a transaction that occurred on Thursday, May 1st. The stock was sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the transaction, the director now directly owns 6,371 shares of the company's stock, valued at approximately $3,312,920. This represents a 27.36% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Mark Brosius sold 215 shares of the stock in a transaction on Monday, June 2nd. The stock was sold at an average price of $549.06, for a total value of $118,047.90. Following the completion of the transaction, the senior vice president now owns 1,768 shares in the company, valued at approximately $970,738.08. This represents a 10.84% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 4,998 shares of company stock valued at $2,611,577 over the last ninety days. 0.70% of the stock is owned by company insiders.

Intuitive Surgical Stock Performance

Shares of ISRG traded down $1.43 during mid-day trading on Friday, reaching $511.57. The company had a trading volume of 1,196,655 shares, compared to its average volume of 1,667,157. The company has a market capitalization of $183.36 billion, a price-to-earnings ratio of 79.89, a P/E/G ratio of 5.85 and a beta of 1.67. The company's 50 day simple moving average is $525.48 and its 200 day simple moving average is $538.67. Intuitive Surgical, Inc. has a 1-year low of $413.82 and a 1-year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating the consensus estimate of $1.71 by $0.10. The firm had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.19 billion. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. During the same period last year, the company earned $1.50 earnings per share. As a group, equities analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.